Exposure-Response Relationship of Certolizumab Pegol and Achievement of Low Disease Activity and Remission in Patients With Rheumatoid Arthritis

• Main Authors: Stéphane Paul (Author), Hubert Marotte (Author), Arthur Kavanaugh (Author), Philippe Goupille (Author), Tore K. Kvien (Author), Marc deLongueville (Author), Denis Mulleman (Author), William J. Sandborn (Author), Niels Vande Casteele (Author)
• Format: Book
• Published: Wiley, 2020-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Anti‐tumor necrosis factor (anti‐TNF) drugs are often prescribed for the treatment of rheumatoid arthritis (RA) and other immune‐mediated inflammatory diseases. Although this treatment has been shown to be effective in many patients, up to 40% of patients do not achieve disease control. Drug concent...